Mobile Enhancement of Motivation in Schizophrenia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03059771|
Recruitment Status : Recruiting
First Posted : February 23, 2017
Last Update Posted : August 22, 2017
|Condition or disease||Intervention/treatment|
|Schizophrenia Schizo Affective Disorder Psychosis||Behavioral: Mobile Enhancement of Motivation (MEMS) Behavioral: Control|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Mobile Enhancement of Motivation in Schizophrenia: A Pilot Trial of a Personalized Text Message Intervention for Motivation Deficits|
|Actual Study Start Date :||February 28, 2017|
|Estimated Primary Completion Date :||July 2018|
|Estimated Study Completion Date :||July 2018|
Experimental: Mobile Enhancement of Motivation (MEMS)
Facilitators will first collaboratively help participants set personal recovery-goals using Collaborative Goal Technology (Clarke et al., 2006). Participants will then receive three sets of interactive text messages each weekday for eight weeks to reinforce and cue goal completion.
Behavioral: Mobile Enhancement of Motivation (MEMS)
The MEMS group will engage in a goal-setting session and then receive personalized text-messages to support goal attainment.
Active Comparator: Control
Participants will only engage in a goal-setting session where facilitators will collaboratively help participants set personal recovery-goals using Collaborative Goal Technology (Clarke et al., 2006).
The control group will only engage in a goal-setting session.
- Goal completion [ Time Frame: follow-up (8 weeks) ]The percentage of baseline goals participants completed over the eight-week period will be assessed at the follow-up assessment.
- Motivation and Pleasure Scale-Self-Report (MAP-SR) [ Time Frame: baseline and follow-up (8 weeks) ]The MAP-SR is a self-report measure 15-item self-report measure that assesses participant's level of motivation and pleasure in several domains, including work and recreational activities. It has been found to be valid and reliable in a schizophrenia-spectrum sample (Llerena, et al., 2013).
- Intrinsic Motivation Index [ Time Frame: baseline and follow-up (8 weeks) ]The 3-item Intrinsic Motivation Index (Nakagami et al., 2008) from the clinician-rated Quality of Life Scale (Heinrichs et al., 1984) will be used to assess trait-like intrinsic motivation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03059771
|Contact: Lauren Luther, MSemail@example.com|
|United States, Indiana|
|Midtown Community Mental Health Center||Recruiting|
|Indianapolis, Indiana, United States, 46208|
|Contact: Lauren Luther|